The COCOA-PAD II Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 190 participants.
Also called NCT04794530
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 190 participants
- Sponsor
- Registry
-
NCT04794530
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT04794530. Randomized; quadruple masking; primary purpose treatment. Start 2021-11-19 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The COCOA-PAD II Trial
- Acronym
- COCOA-PAD II
- Condition
- Peripheral Artery Disease
- Intervention (Drug)
- cocoa flavanols
- Intervention (Drug)
- placebo
- Lead sponsor
- Northwestern University
- Collaborator
- National Institute on Aging (NIA)
- Collaborator
- University of Minnesota
- Collaborator
- University of Chicago
Record details
- Record id
cardio:ct-nct04794530- Content hash
a0e5a8a9525247ba44c7f94c65ce25f36f057955f7c5d67b3e7d4194e35161c7